Chou, J., Su, H., Chen, L., Liao, Y., Hartman-Frey, C., Lai, Y., . . . Chan, M. W. (2010). Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Laboratory Investigation (00236837), 90(3), 414-425. https://doi.org/10.1038/labinvest.2009.138

Chou, Jian-Liang, et al. "Promoter Hypermethylation of FBXO32, a Novel TGF-β/SMAD4 Target Gene and Tumor Suppressor, Is Associated with Poor Prognosis in Human Ovarian Cancer." Laboratory Investigation (00236837) 90, no. 3 (2010): 414-425. https://doi.org/10.1038/labinvest.2009.138.

Chou, Jian-Liang, et al. "Promoter Hypermethylation of FBXO32, a Novel TGF-β/SMAD4 Target Gene and Tumor Suppressor, Is Associated with Poor Prognosis in Human Ovarian Cancer." Laboratory Investigation (00236837), vol. 90, no. 3, 2010, pp. 414-425, https://doi.org/10.1038/labinvest.2009.138.